You are here

  • Home
  • Archive
  • Volume 25, Issue 3
  • Cyclophosphamide, Hydroxyurea, Actinomycin D, Methotrexate, and Vincristine in the Treatment of Gestational Trophoblastic Neoplasia

Article info

Article menu
Download PDFPDF
Gestational Trophoblastic Neoplasia
Cyclophosphamide, Hydroxyurea, Actinomycin D, Methotrexate, and Vincristine in the Treatment of Gestational Trophoblastic Neoplasia

Authors

  • Mandy Man Yee Chu Department of Obstetrics and Gynecology, The University of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong Special Administrative Region; and PubMed articlesGoogle scholar articles
  • Yaomei Ma Department of Obstetrics and Gynecology, Tianjin Central Hospital of Obstetrics and Gynecology, Tianjin, China. PubMed articlesGoogle scholar articles
  • Ka Yu Tse Department of Obstetrics and Gynecology, The University of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong Special Administrative Region; and PubMed articlesGoogle scholar articles
  • Karen Kar Loen Chan Department of Obstetrics and Gynecology, The University of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong Special Administrative Region; and PubMed articlesGoogle scholar articles
  • Hextan Yuen Sheung Ngan Department of Obstetrics and Gynecology, The University of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong Special Administrative Region; and PubMed articlesGoogle scholar articles
  1. Address correspondence and reprint requests to Mandy Man Yee Chu, MRCOG, Department of Obstetrics and Gynecology, The University of Hong Kong, Queen Mary Hospital, 102 Pokfulam Rd, Hong Kong, Hong Kong Special Administrative Region. E-mail: chumy@hku.hk.

Citation

Chu MMY, Ma Y, Tse KY, et al
Cyclophosphamide, Hydroxyurea, Actinomycin D, Methotrexate, and Vincristine in the Treatment of Gestational Trophoblastic Neoplasia
International Journal of Gynecologic Cancer 2015;25:498-503.

Publication history

  • Received September 9, 2014
  • First published March 1, 2015.
Online issue publication 
February 26, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Copyright © 2015 by IGCS and ESGO